Risk factor
Very poor trading liquidity
Profitability factor
Favourable analyst view
About
PT Famon Awal Bros Sedaya Tbk operates a network of hospitals throughout Indonesia. The company delivers a broad spectrum of specialized medical services, encompassing cardiovascular treatment, orthopedic sports medicine, trauma care, oncology (cancer treatment), neurological and brain health, ophthalmology, maternal and pediatric services, and urology. Additionally, it offers clinical laboratory analysis, in-home care, medical transportation, and digital consultation services, among other diverse healthcare provisions. Founded in 1997 and headquartered in Kemayoran, Indonesia, PT Famon Awal Bros Sedaya Tbk is a subsidiary of PT Famon Obor Maju.
Company Valuation
From both historical and forecast perspectives, the stock is considerably overpriced compared to similar stocks. Specifically, the stock is 'expensive' on P/E, overvalued
Target Price
The average target price of PRAY.JK is 1200 and suggests 64.4% upside potential. Usually, this means a BUY recommendation among investment firms, or a recommendation to i